Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) currently has a daily average trading volume of 12.43M but it saw 7685665 shares traded in last market. With a market cap of 19.41B USD, the company’s current market price of $16.94 came rising about 2.36 while comparing to the previous closing price of $16.55. In past 52 weeks, the stock remained buoying in the range of price level as high as $22.80 and as low as $12.47.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the JP Morgan which upgraded the stock as “Overweight” in its note to investors issued on May 12, 2025, recommending a price target of $23 for it. Argus upgraded its recommendation for the stock as a “Buy” from “Hold” on July 10, 2024 while assigning a price target of $20. JP Morgan also issued its recommendations for the stock as it upgraded the price target for the stock is $14.
Over the week, TEVA’s stock price is moving 0.41% up while it is 18.54% when we observe its performance for the past one month. Year-to-date it is -23.14% down and over the past year, the stock is showing an upside performance of 0.77%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0.64 while estimate for next year EPS is 2.55. In next quarter, company is expected to be making quarterly sales of $4.49B as analysts are expecting the sales for current fiscal year at $17B and seeing the company making $17.12B in sales next year. Moreover, analysts are in estimates of $4.38B for current-quarter revenue.
Currently, Teva- Pharmaceutical Industries Ltd. ADR’s total number of outstanding shares is 1.15B with 0.00% of that held by the insiders while 64.14% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -5.65% and return on equity (ROE) at -18.98%. It has a 6.13 of forward P/E ratio. Stock’s beta reads 0.60. Stock has a price to book (P/B) ratio of 3.10 while price to sale or P/S ratio amounts to 1.17. Its return on asset (ROA) is -3.17% on average.
